The Prime Minister's Economic Advisory Council has suggested a complex combination of three pricing models to fix retail prices of 348 essential drugs to balance industry's concerns and public health. The proposal, however, has drawn the ire of drug makers who say it is a watered down version of the health ministry's proposals. The council has proposed that for medicines facing "insufficient competition" or a monopoly-like situation, the retail price should...
More »SEARCH RESULT
AIDAN proposes another pricing model for essential drugs by Khomba Singh
A non-government organisation campaigning for cheaper essential drugs has proposed an alternative pricing model that seeks to fix retail prices at the average price of all brands in a segment. The proposal of the All India Drug Action Network (AIDAN) is being examined by the Department of Pharmaceuticals (DoP), an official said. AIDAN says its new pricing mechanism, which excludes brands that account for the top 20% by sales, will make...
More »Prices of 348 essential drugs to be controlled
-The Times of India The Centre on Thursday responded to the Supreme Court's concern over spiralling prices of essential medicines and promised to make all-out efforts to put under strict price control regime all the 348 drugs included in the National List of Essential Medicines (NLEM), 2011. A bench comprising Justices G S Singhvi and S J Mukhopadhaya had, in the last hearing, expressed concern over the shrinking list of medicines under...
More »New pharma policy to cap prices of 60% drugs by Namrata Nandakumar & CH Unnikrishnan
India’s new pharmaceutical policy seeks to bring at least 400 essential medicines—or 60% of the drugs sold in the country—under the government’s pricing control. The Department of Pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing. Currently, the government controls the prices of only 34 essential medicines. The draft says the policy, to be finalized...
More »Prescription For Trouble by Arindam Mukherjee
Mulling It Over 100% FDI allowed in pharma sector through automatic route Seven top Indian firms have been acquired by MNCs in the past six years Fear of price rise in generic medicines if MNCs control market Health, commerce ministries want FDI to go through approvals PMO meeting key ministries next month to take a decision *** Prime Minister Manmohan Singh has always been firm in reminding domestic industry that their fear...
More »